The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control.

scientific article published in January 2011

The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID21519726

P50authorItziar AbeteQ43264794
Santiago Navas-CarreteroQ44181198
P2093author name stringJ A Martínez
L Forga
I Bondia-Pons
M A Zulet
P López-Legarrea
R de la Iglesia
P433issue1
P304page(s)16-26
P577publication date2011-01-01
P1433published inNutrición HospitalariaQ6047211
P1476titleThe reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control
P478volume26

Reverse relations

cites work (P2860)
Q28069172Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention
Q60472229An integrated transcriptomic and epigenomic analysis identifies CD44 gene as a potential biomarker for weight loss within an energy-restricted program
Q35729080Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet
Q64088783Associations between olfactory pathway gene methylation marks, obesity features and dietary intakes
Q36820389Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption
Q92376772Changes in Anxiety and Depression Traits Induced by Energy Restriction: Predictive Value of the Baseline Status
Q90352392Changes in lysophospholipids and liver status after weight loss: the RESMENA study
Q47373483DNA Methylation and Hydroxymethylation Levels in Relation to Two Weight Loss Strategies: Energy-Restricted Diet or Bariatric Surgery.
Q33813760DNA hypermethylation of the serotonin receptor type-2A gene is associated with a worse response to a weight loss intervention in subjects with metabolic syndrome
Q36088391Differential DNA Methylation in Relation to Age and Health Risks of Obesity
Q60472227Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake
Q64121823Epigenome-wide association study in peripheral white blood cells involving insulin resistance
Q38705139Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction
Q58796242Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets
Q92404330Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia
Q59792704Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile
Q47373575LINE-1 methylation levels, a biomarker of weight loss in obese subjects, are influenced by dietary antioxidant capacity.
Q92853769Methylome-Wide Association Study in Peripheral White Blood Cells Focusing on Central Obesity and Inflammation
Q38259737Personalized weight loss strategies-the role of macronutrient distribution
Q37281728SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction
Q36646856Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial
Q60922837Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

Search more.